Home › Stocks › BGMSP

BGMSP — CYCLACEL PHARMACEUTICALS INC

Reported value held$83.83K
Funds holding (latest)2
Sector—

BGMSP (CYCLACEL PHARMACEUTICALS INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 2 funds have reported positions historically, with the sum of their latest reported stakes valued at $83.83K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Q1 2025 — 2 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors history 12.17K $58.66K 0.00% New
UBS Group AG history 5.38K $25.17K 0.00% Add

Q4 2024 — 1 funds

FundSharesValuePortfolio WeightChange
UBS Group AG history 84 $612 0.00% New

Q4 2023 — 1 funds

FundSharesValuePortfolio WeightChange
UBS Group AG history 17 $277 0.00% New

Q2 2023 — 1 funds

FundSharesValuePortfolio WeightChange
UBS Group AG history 6 $66 0.00% Reduce

Q1 2023 — 2 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors history 48.23K $748.05K 0.00% New
UBS Group AG history 23 $321 0.00% New

Q3 2022 — 1 funds

FundSharesValuePortfolio WeightChange
UBS Group AG history 548 $4.00K 0.00% Add

New Positions (latest)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 2 funds)

FundQ1 2025Q4 2024Q4 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q4 2021
Citadel Advisors 12.17K — — — 48.23K — — — —
UBS Group AG 5.38K 84 17 6 23 548 503 629 677

Download holders (CSV)